SAWAI
LIVE

Serial Number

79227025

Owner

SAWAI PHARMACEUTICAL CO., LTD.

Attorney

Shauna M. Wertheim

Filing Date

Sep 28, 2017

Add to watchlist:

No watchlists yet
View on USPTO

SAWAI Trademark

Serial Number: 79227025 • Registration: 5759802

SAWAI is a trademark filed by SAWAI PHARMACEUTICAL CO., LTD. on September 28, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

SAWAI PHARMACEUTICAL CO., LTD. (7 trademarks)

ASAHI-KU, OSAKA-SHI, OSAKA , JP

Entity Type: 99

Trademark Details

Filing Date

September 28, 2017

Registration Date

May 28, 2019

Published for Opposition

March 12, 2019

Cancellation Date

December 12, 2025

Goods & Services

Banners of paper; paper bunting; hygienic hand towels of paper; towels of paper; table napkins of paper; hand towels of paper; handkerchiefs of paper; paper and cardboard; stationery; printed matter, namely, business cards and integrated reports featuring information regarding pharmaceutical clinical trials; printed photographs; photograph stands

Pharmaceutical preparations for medical or veterinary purposes for the prevention and treatment of disorders or diseases of the central nervous system, the peripheral nervous system, the musculo-skeletal system, the cardiovascular system, the respiratory system, the gastrointestinal system, the genitourinary system, the endocrine system, the metabolic system, the immune system, the psychological system; pharmaceutical preparations for medical or veterinary purposes for use in dermatology, oncology, ophthalmology, the treatment of allergies, the treatment of infections, the treatment of circulatory system diseases, the treatment of diabetes, the treatment of hyperlipidemia, the treatment of osteoporosis; pharmaceutical preparations in the nature of vitamins and vitamin preparations for medical or veterinary purposes; diagnostic pharmaceutical preparations for medical or veterinary purposes; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Chemicals and chemical preparations for use in the manufacture of pharmaceuticals

Filing History

CANCELLED SECTION 71
Dec 12, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 28, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 4, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 13, 2019 FICS
FINAL DISPOSITION PROCESSED
Sep 13, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 28, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
May 28, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2019 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Mar 8, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 20, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 20, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 20, 2019 NONP
ASSIGNED TO LIE
Feb 1, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 17, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 17, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 16, 2018 GNFN
FINAL REFUSAL E-MAILED
Oct 16, 2018 GNFR
FINAL REFUSAL WRITTEN
Oct 16, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 4, 2018 TROA
REFUSAL PROCESSED BY IB
Mar 30, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 14, 2018 RFCS
REFUSAL PROCESSED BY MPU
Mar 14, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 8, 2018 RFCR
NON-FINAL ACTION WRITTEN
Mar 7, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 3, 2018 MAFR
ASSIGNED TO EXAMINER
Feb 27, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 20, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 15, 2018 REPR